Protagenic Therapeutics, Inc.\new (PTIX) Cash & Equivalents (2013 - 2025)
Protagenic Therapeutics, Inc.\new (PTIX) reported Cash & Equivalents of $2.21 million for fiscal Q3 2026 (quarter ended Dec 31, 2025), down 18.7% from the prior quarter.
Powered by 
Analysis
Protagenic Therapeutics, Inc.\new (PTIX) Cash & Equivalents (2013 - 2025) Analysis & Trends
At the end of FY2025 (ended Mar 31, 2025), Protagenic Therapeutics, Inc.\new posted Cash & Equivalents of $14,531.
- Cash & Equivalents has a five-year compound annual growth rate of -53.5% (FY2020 to FY2025).
- By fiscal year, Cash & Equivalents came in at $79,568 in FY2024 (-93.8%), $1.29 million in FY2023 (+498.5%), $215,189 in FY2022 (-60.2%) and $541,171 in FY2021 (-19.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Protagenic Therapeutics, Inc.\new | 1.36 Mn | 1.36 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 2.21 Mn |
| Sep 30, 2025 | 2.72 Mn |
| Mar 31, 2025 | 14,531.00 |
| Dec 31, 2024 | 79,568.00 |
| Sep 30, 2024 | 71,396.00 |
| Jun 30, 2024 | 924,596.00 |
| Mar 31, 2024 | 1,625.00 |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | 153,332.00 |
| Jun 30, 2023 | 219,435.00 |
| Mar 31, 2023 | 138,491.00 |
| Dec 31, 2022 | 215,189.00 |
| Sep 30, 2022 | 158,323.00 |
| Jun 30, 2022 | 338,666.00 |
| Mar 31, 2022 | 482,175.00 |
| Dec 31, 2021 | 541,171.00 |
| Sep 30, 2021 | 460,115.00 |
| Jun 30, 2021 | 11.93 Mn |
| Mar 31, 2021 | 191,674.00 |
| Dec 31, 2020 | 671,091.00 |
API Access
Protagenic Therapeutics, Inc.\new Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PTIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();